Obesity, risk factor in COVID-19
DOI:
https://doi.org/10.5281/zenodo.14876593Keywords:
Obesity, Coronavirus Infections, SARS-CoV-2, COVID-19, Overweight, PandemicAbstract
Introduction: obesity, as a risk factor and chronic non-communicable disease, represents a health problem for populations, especially for those patients who are infected by SARS-CoV-2.
Objective: To characterize the role of obesity as a predisposing factor for complications of COVID-19.
Methods: an updated bibliographic review on the subject was carried out for a total of 44 bibliographies. Scientific articles in English and Spanish were used, available in databases such as: PubMed, Scopus, Medline, SciELO, and in the Google Academic search engine.
Development: the evidence available to date suggests that people with chronic non-communicable diseases are at greater risk of serious complications from COVID-19 infection.
Chronic inflammation due to excess adipose tissue, changes in the immune system, the level of ECA2 expression, vitamin D deficiency, intestinal dysbiosis, as well as apnea, are characteristics of overweight patients that are related in a certain way with COVID-19.
Conclusions: obesity represents a predisposing factor for the development of complications inCOVID-19. Obese patients may have compromised immune, cardiovascular or respiratory systems, so it is necessary to alert this vulnerable population of the danger that being infected with SARS-CoV-2, represents for their health.
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China,2019. N Engl J Med. 2020 [citado 23/05/2020];382:727-733. Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa2001017
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020[citado 31/05/2020]; 382:1708-1720. Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032
Gao Y, Yan T, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science.2020[citado 26/05/2020];368(6488):779-782. Disponible en: https://science.sciencemag.org/content/368/6492/779.abstract
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med.2020 [citado 23/05/ 2020]; 26(4): 450–452. Disponible en: https://www.nature.com/articles/s41591-020-0820-9
Santos Velázquez T, Panizo Bruzón SE, Díaz Couso Y, Sánchez Alonso N. Conocimientos de estomatólogos sobre prevención y control de la COVID-19. Rev Electron Zoilo. 2020[citado 02 /06/2020];45(3).Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2292
Paules CI, Marston HD, Fauci AS. Coronavirus Infections—More Than Just the Common Cold. JAMA. 2020[citado 23/05/2020]; 323(8):707-708.Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815
Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev Haban Cienc Méd. 2020[citado 29/05/2020];19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 [citado 23/05/2020];109:102433. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0896841120300469
MINSAP. Cuba reporta 44 casos de COVID-19, un fallecido y 40 altas médicas.Cubadebate.06/11/2020;Salud.Disponible en: https://www.google.com/amp/www.cubadebate.cu/noticias/2020/11/06/cuba-reporta-44-casos-de-covid-19-un-fallecido-y-40-altas-medicas-video/amp/
Plasencia Urizarri TM, Aguilera Rodríguez R, Almaguer Mederos LE. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Rev Haban Cienc Méd .2020 [citado 04/11/2020]; 19(Supl 1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000400002&lng=es
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020[citado 23/05/2020]; 8(4):21. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118626/
Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory síndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infec. 2020[citado 23/05/2020]; 53(3): 404-412. Disponible en: https://www.sciencedirect.com/science/article/pii/S1684118220300402
Rosero RJ, Polanco JP, Sánchez P, Hernández E, Pinzón JB, Lizcano F. Obesidad: un problema en la atención de Covid-19. Rev Repert Med Cir. 2020[citado 23/05/2020]; 29(1):10-14. Disponible en: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1035
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet.2020 [citado 23/05/2020];395(10229):1054-1062.Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620305663
Stefan N, Birkenfeld AL, Schulze MB. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol.2020[citado 29/05/2020];16(7):341-342.Disponible en: https://www.nature.com/articles/s41574-020-0364-6?report=reader
Simonnet A , Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐ 2 (SARS‐ CoV‐ 2) requiring invasive mechanical ventilation. Obesity (Silver Spring).2020[citado 29/05/2020];28(7):1195-1199. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22831?af=R
Ryan DH, Ravussin E, Heymsfield S. COVID 19 and the Patient with Obesity. Obesity (Silver Spring).2020 [citado 29/05/2020]; 28(5):847. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228389/
Caussy C, Wallet F, Laville M, Disse E. Obesity is associated with severe forms of COVID‐19. Obesity.2020 [citado 29/05/2020]; 28(7). Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22842
Frasca D, Blomberg BB. The Impact of Obesity and Metabolic Syndrome on Vaccination Success. Basel Karger.2020[citado 22/05/2020]; 43:86-97. Disponible en: https://www.karger.com/Article/Abstract/504440#menu
Frasca D, Ferracci F, Diaz A, Romero M, Lechner S, Blomberg BB. Obesity decreases B cell responses in young and elderly individuals. Obesity (Silver Spring).2016 [citado 22/05/2020]; 24(3):615-625. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769695/
Petrova D, Salamanca Fernández E, Barranco MR, Pérez PN, Jiménez Moleón JJ, Sánchez MJ, et al. La obesidad como factor de riesgo en personas con COVID-19: Posibles mecanismos e implicaciones. Aten Primaria.2020 [citado 22/05/2020];52(7):496-500. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247450/
Sattar N, McInnes IB, McMurray JV. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation. 2020[citado 22/05/2020]; 142(1): 4-6. Disponible en: https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.120.047659
Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord. 2000[citado 22/05/2020];24(4):23-27. Disponible en: https://www.nature.com/articles/0801497
Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol.2008 [citado 29/05/2020]; 28(7):1304–1310. Disponible en: https://www.ahajournals.org/doi/full/10.1161/atvbaha.108.165100
O’Rourke RW, Kay T, Scholz MH, Diggs B, Jobe BA, Lewinsohn DM, et al. Alterations in T-Cell Subset Frequency in Peripheral Blood in Obesity. Obes Surg.2005[Citado 22/05/2020]; 15(10):1463–1468. Disponible en: https://link.springer.com/article/10.1381/096089205774859308
Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine.2012[citado 22/05/2020];30(26):3937-3943. Disponible en: https://www.sciencedirect.com/science/article/pii/S0264410X1200463X
Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, et al. Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020 [citado 20/05/2020]; 43(3)209-214. Disponible en: https://pesquisa.bvsalud.org/controlecancer/resource/pt/mdl-32164090?src=similardocs
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol.2020 [citado 23/05/2020]; 94(7). Disponible en: https://jvi.asm.org/content/94/7/e00127-20
Batlle D, Wysocki J, Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci(Lond).2020[citado 23/05/2020]; 134(5):543-545. Disponible en: https://portlandpress.com/clinsci/article/134/5/543/222345/Soluble-angiotensin-converting-enzyme-2-a
Hoffmann M, Kleine Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 [citado 23/05/2020]; 181(2):271-280. Disponible en: https://www.sciencedirect.com/science/article/pii/S0092867420302294
Giralt Herrera A, Rojas Velázquez JM, Leiva Enríquez J. Relación entre COVID-19 e Hipertensión Arterial. Rev Haban Cienc Méd.2020 [citado 01/06/20];19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3246
Bouillon R, Marcocci C , Carmeliet G, Bikle D , White JH , Hughes BD, et al. Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocr Rev.2019 [citado 01/06/20]; 40(4):1109-1151. Disponible en https://academic.oup.com/edrv/article/40/4/1109/5126915?login=true
Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020 [citado 21/05/2020]; 21(6):13034.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235532/
Carter S, Baranauskas M, Fly A. Considerations for obesity, vitamin D, and physical activity amidst the COVID‐19 pandemic. Obesity. 2020[citado 21/05/2020];28(7):1176-1177. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22838
Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P , Dubnov Raz G, et al. Vitamin D supplementation to prevent acute respiratory infections: Individual participant data meta-analysis. Health Technol Assess.2019 [citado 21/05/2020];23(2):1-44.Disponible en: https://eprints.utas.edu.au/33168/
Grant W, Lahore H , McDonnell S, Baggerly C , French C , Aliano J, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020[citado 21/05/2020];12(4):988. Disponible en: https://www.mdpi.com/2072-6643/12/4/988
Aasheim ET, Hofsø D, Hjelmesœth J, Birkeland KI, Bøhmer T. Vitamin status in morbidly obese patients: A cross-sectional study. Am J Clin Nutr. 2008 [citado 21/05/2020]; 87(2):362-369. Disponible en: https://academic.oup.com/ajcn/article/87/2/362/4633366
Molnár D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord.2004 [citado 21/05/2020]; 28(10):1197-1202. Disponible en: https://www.nature.com/articles/0802719
Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem.2002 [citado 21/05/2020];35(8):627-631. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0009912002003636
Jin YH, Cai L, Cheng ZS, Hong Cheng H, Tong Deng T , Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res.2020 [citado 21/05/2020]; 7(1):4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003341/
Valencia Flores M, Rebollar GV, Orea TA, Castaño Meneses A, García Ramos G, González Barranco J. Apnea del sueño en el paciente obeso. Rev Endocrinol Nutr.2001 [citado 21/05/2020];9(2): 97-102. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=8041
Olivi H. Apnea del sueño: cuadro clínico y estudio diagnóstico. Rev Med Clin Condes.2013 [citado 21/05/2020]; 24(3): 359-373. Disponible en: https://www.sciencedirect.com/science/article/pii/S0716864013701731
Puig Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020 [citado 21/05/2020]; 68(1):2-5. Disponible en: https://link.springer.com/article/10.1007/s12020-020-02294-5
Elias Malavazos A , Corsi Romanelli MM, Bandera F , Iacobellis G. Targeting the Adipose Tissue in COVID- 19. Obesity.2020 [citado 22/05/2020]; 28(7):1178-1179. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22844
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Revista HolCien
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Centro Provincial de Información de Ciencias Médicas. Universidad de Ciencias Médicas de Holguín. Cuba.
Política de acceso y distribución
El total de los artículos publicados son contribuciones de acceso abierto, que se distribuyen según los términos de la Licencia Creative Commons Atribución–NoComercial 4.0 que permite el uso, distribución y reproducción no comerciales y sin restricciones en cualquier medio, siempre que sea debidamente citada la fuente primaria de publicación.
